Reproductive endocrinology

From Klinefelter Syndrome to High Grade Aneuploidies: Expanding the Gene-dosage Effect of Supernumerary X Chromosomes

J Clin Endocrinol MetabPublished Cross-sectional study

An erratum to this article was published (J Clin Endocrinol Metab, 12 Jul 2024 ↗)

Authors' conclusion

The increase in the number of extra-Xs is associated with a "dose-dependent" progressive impairment in steroid producing glands, thyroid function, cardiac structure, and performance.

Study context

Population
Subjects with high-grade aneuploidies of X and Y sex chromosomes (HGAs) and age-matched subjects with 47,XXY Klinefelter syndrome (KS)23 HGA, 46 KS
Exposure
Subjects with HGAs vs age-matched 47,XXY KS, by number of extra-Xs
Outcome
Clinical, hormonal, metabolic and echocardiographic features by number of extra-Xs
Methodological detailsage-matched, validation cohort pubertal stage-matched, Second cohort of 46 pubertal stage-matched KS subjects used for validation
  • Age-matched
  • Validation cohort pubertal stage-matched
  • Second cohort of 46 pubertal stage-matched KS subjects used for validation

Main finding

As reported in the abstract

  • More extra-Xs associated with progressive adverse effect on height, pubertal development, testicular volume and function, adrenal steroidogenesis and thyroid function
  • Progressive linear increase in ACTH and decrease in cortisol/ACTH ratios
  • Weight, BMI, Sertoli cell function, lipid profile and glucose tolerance post-OGTT worse in HGA vs KS
  • Linear association with reduced left and right end-diastolic diameters and reduced ejection fraction

Observational data: associations, not effects.

Original publication

From Klinefelter Syndrome to High Grade Aneuploidies: Expanding the Gene-dosage Effect of Supernumerary X Chromosomes. J Clin Endocrinol Metab. Published 9 January 2024. doi:10.1210/clinem/dgad730

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.